Efficacy and safety of biosimilar (Inflectra) in patients with ankylosing spondylitis: multicenter and observational one year follow-up study (CROSBI ID 718601)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Grubišić, Frane ; Grazio, Simeon ; Anić, Branimir ; Barešić, Marko ; Novak, Srđan ; Anić, Felina ; Prus, Višnja ; Gudelj Gračanin, Ana ; Morović-Vergles, Jadranka ; Martinović-Kaliterna, Danijela ; Borić, Katarina ; Kehler, Tatjana
engleski
Efficacy and safety of biosimilar (Inflectra) in patients with ankylosing spondylitis: multicenter and observational one year follow-up study
The aim of the study was to evaluate the efficacy and safety of biosimilar Inflectra in patients with AS.
biosimilar ; infliximab ; ankylosing spondylitis ;
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
51-51.
2017.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Podaci o skupu
19th Asia Pacific League of Associations for Rheumatology Congress – APLAR 2017 and 3rd Annual Conference of the Emirates Society for Rheumatology – ESR
poster
16.10.2017-20.10.2017
Dubai, Ujedinjeni Arapski Emirati
Povezanost rada
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje), Kliničke medicinske znanosti
